See also this year's filing and all EDGAR filings for this company.
PDF Report 0001742927_2023_REVIVA_PHARMACEUTICALS_HOLDINGS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001742927, REVIVA PHARMACEUTICALS HOLDINGS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 18,923,675 |
| 4 | LiabilitiesCurrent | 6,039,840 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 567,439 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,358,734 |
| 9 | ResearchAndDevelopmentExpense | 18,947,874 |
| 10 | remainder_Expenses | 20,777 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -11,907 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 18,923,675 |
| 1 | Liabilities | 6,607,279 |
| 2 | Expenses | 24,327,385 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 12,316,396 |
| 5 | NetIncome | -24,339,292 |
| 6 | ComprehensiveNetIncome | -24,339,292 |
| 7 | BaseVar | 24,935,123 |
| 8 | EconomicCapitalRatio | -0.247 |